Ajovy and Blindness - a phase IV clinical study of FDA data

Summary:

Blindness is reported as a side effect among people who take Ajovy (fremanezumab-vfrm), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Omeprazole, and have Migraine.

The phase IV clinical study analyzes which people have Blindness when taking Ajovy. It is created by eHealthMe based on reports of 8,788 people who have side effects when taking Ajovy from the FDA, and is updated regularly.

What is Ajovy?

Ajovy has active ingredients of fremanezumab-vfrm. eHealthMe is studying from 8,834 Ajovy users. Check the latest studies of Ajovy.

What is Blindness?

Blindness is found to be associated with 1,509 drugs and 1,986 conditions by eHealthMe. Check the latest studies of Blindness.

On Jul, 17, 2026

8,788 people reported to have side effects when taking Ajovy.
Among them, 18 people (0.2%) have Blindness.

Among these 18 people:

How long have people been on Ajovy when they have Blindness? *

What is the gender of people who have Blindness when taking Ajovy? *

female: 81.25 %
male: 18.75 %

What is the age of people who have Blindness when taking Ajovy? *

What are other drugs people take besides Ajovy? *

What are other side effects people have besides Blindness? *

Headache (pain in head): 4 people, 22.22%
Weakness: 3 people, 16.67%
Migraine (headache): 3 people, 16.67%
Vision Blurred: 3 people, 16.67%
Dizziness: 3 people, 16.67%
Pain: 2 people, 11.11%
Hypoaesthesia (reduced sense of touch or sensation): 2 people, 11.11%
Memory Loss: 2 people, 11.11%
Confusional State: 2 people, 11.11%
Joint Pain: 2 people, 11.11%

What are the existing conditions these people have? *

Migraine (headache): 5 people, 27.78%
Headache (pain in head): 3 people, 16.67%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 11.11%
Stress And Anxiety: 1 person, 5.56%
Neuralgia (pain in one or more nerves): 1 person, 5.56%
Muscle Spasms (muscle contraction): 1 person, 5.56%
Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 5.56%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 5.56%
Hypersensitivity: 1 person, 5.56%
High Blood Cholesterol: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Ajovy and have Blindness?

- Check whether Blindness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ajovy:

Ajovy (8,834 reports)

Blindness treatments and more:

Blindness (45,948 reports)

Browse all side effects of Ajovy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blindness:

Blindness (1,509 drugs)

Browse all the conditions that are associated with Blindness:

Blindness (1,986 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fremanezumab-vfrm (the active ingredients of Ajovy) and Ajovy (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.